FR3149209B1 - Composition cosmétique comprenant une endolysine dérivée de phage de Staphylococcus aureus et un alcool aromatique - Google Patents

Composition cosmétique comprenant une endolysine dérivée de phage de Staphylococcus aureus et un alcool aromatique

Info

Publication number
FR3149209B1
FR3149209B1 FR2305548A FR2305548A FR3149209B1 FR 3149209 B1 FR3149209 B1 FR 3149209B1 FR 2305548 A FR2305548 A FR 2305548A FR 2305548 A FR2305548 A FR 2305548A FR 3149209 B1 FR3149209 B1 FR 3149209B1
Authority
FR
France
Prior art keywords
staphylococcus aureus
aromatic alcohol
composition
cosmetic composition
aureus phage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2305548A
Other languages
English (en)
Other versions
FR3149209A1 (fr
Inventor
Sylvie Jalenques
Eric Duponchel
Cruz Olivier Da
Géraldine Lerebour
Julia Puech
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR2305548A priority Critical patent/FR3149209B1/fr
Priority to EP24729012.5A priority patent/EP4719330A1/fr
Priority to PCT/EP2024/065089 priority patent/WO2024246325A1/fr
Priority to CN202480040017.1A priority patent/CN121358455A/zh
Publication of FR3149209A1 publication Critical patent/FR3149209A1/fr
Application granted granted Critical
Publication of FR3149209B1 publication Critical patent/FR3149209B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

Composition cosmétique comprenant une endolysine dérivée de phage de Staphylococcus aureus et un alcool aromatique La présente invention concerne une composition, notamment cosmétique, comprenant, dans un milieu physiologiquement acceptable au moins une endolysine dérivée d’un phage de Staphylococcus aureus et au moins un alcool aromatique de formule (I). Elle concerne également l’utilisation d’une telle composition pour prévenir et/ou traiter un désordre cutané lié à une colonisation par Staphylococcus aureus chez un individu en ayant besoin, et en particulier pour prévenir et/ou traiter de l’acné et/ou de l’eczéma chez un individu en ayant besoin, et un procédé cosmétique non thérapeutique de soin des matières kératiniques, en particulier de la peau, comprenant au moins une étape d’application topique sur lesdites matières kératiniques d’une telle composition. Figure pour l’abrégé : Aucune
FR2305548A 2023-06-02 2023-06-02 Composition cosmétique comprenant une endolysine dérivée de phage de Staphylococcus aureus et un alcool aromatique Active FR3149209B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR2305548A FR3149209B1 (fr) 2023-06-02 2023-06-02 Composition cosmétique comprenant une endolysine dérivée de phage de Staphylococcus aureus et un alcool aromatique
EP24729012.5A EP4719330A1 (fr) 2023-06-02 2024-05-31 <smallcaps/>? ? ?staphylococcus aureus? ? ? ? ?composition cosmétique comprenant une endolysine dérivée d'un phage deet un alcool aromatique
PCT/EP2024/065089 WO2024246325A1 (fr) 2023-06-02 2024-05-31 Composition cosmétique comprenant une endolysine dérivée d'un phage de staphylococcus aureus et un alcool aromatique
CN202480040017.1A CN121358455A (zh) 2023-06-02 2024-05-31 包含衍生自金黄色葡萄球菌噬菌体的内溶素和芳族醇的化妆品组合物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2305548 2023-06-02
FR2305548A FR3149209B1 (fr) 2023-06-02 2023-06-02 Composition cosmétique comprenant une endolysine dérivée de phage de Staphylococcus aureus et un alcool aromatique

Publications (2)

Publication Number Publication Date
FR3149209A1 FR3149209A1 (fr) 2024-12-06
FR3149209B1 true FR3149209B1 (fr) 2026-04-03

Family

ID=88585290

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2305548A Active FR3149209B1 (fr) 2023-06-02 2023-06-02 Composition cosmétique comprenant une endolysine dérivée de phage de Staphylococcus aureus et un alcool aromatique

Country Status (1)

Country Link
FR (1) FR3149209B1 (fr)

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2668080B1 (fr) 1990-10-17 1993-08-13 Seppic Sa Compositions auto-emulsionnables a base d'alcools gras, leur procede de preparation et leur utilisation pour la realisation d'emulsions.
FR2712595B1 (fr) 1993-11-19 1995-12-22 Seppic Sa Un concentré comportant des alkylglycosides et ses utilisations.
FR2756176B1 (fr) 1996-11-26 1998-12-18 Oreal Composition cosmetique comprenant un compose fluore et presentant un confort ameliore
FR2762317B1 (fr) 1997-04-21 1999-07-09 Seppic Sa Composition a base d'alkylpolyglycosides et d'alcools gras, et ses utilisations
US20050118159A1 (en) 2001-12-21 2005-06-02 Stinson Jeffrey R. Truncated lysostaphin molecule with enhanced staphylolytic activity
WO2008155059A2 (fr) 2007-06-19 2008-12-24 Cognis Ip Management Gmbh Mélanges d'hydrocarbures et leur utilisation
WO2010011960A2 (fr) 2008-07-24 2010-01-28 The United State Of America, As Represented By The Secretary Of Agriculture Antimicrobiens triple action réfractaires au développement de résistances
KR101701890B1 (ko) 2009-06-26 2017-02-02 뤼산도 아게 항균제
DK2445515T3 (en) 2009-06-26 2016-07-04 Univ Leuven Kath antimicrobial agents
MX2012002216A (es) 2009-08-24 2012-04-10 Univ Leuven Kath Nueva endolisina obpgplys.
PT104837A (pt) 2009-11-24 2011-05-24 Technophage Investiga O E Desenvolvimento Em Biotecnologia S A P?ptidos de fagos enteroc?cicos e m?todos para a sua utiliza??o
EP2338916A1 (fr) 2009-12-23 2011-06-29 Hyglos Invest GmbH Polypeptides chimériques et leur utilisation dans la décolonisation bactérienne
US9534223B2 (en) 2010-04-27 2017-01-03 Lysando Ag Method of reducing biofilms
GB201018518D0 (en) 2010-11-03 2010-12-15 Univ Leuven Kath Novel endolysin
EP2468856A1 (fr) 2010-12-23 2012-06-27 Lysando Aktiengesellschaft Agents antimicrobiens
WO2012094004A1 (fr) 2011-01-05 2012-07-12 The United States Of America, As Represented By The Secretary Of Agriculture Fusion de peptidoglycane hydrolases à un domaine de transduction des protéines pour éradiquer à la fois les pathogènes gram-positifs extracellulaires et intracellulaires
EP2702070B1 (fr) 2011-04-27 2015-09-30 Lysando AG Nouveaux agents antimicrobiens
DK2705144T4 (da) 2011-05-04 2019-10-21 Micreos Human Health Bv Polypeptid
HK1208494A1 (en) 2012-05-07 2016-03-04 Micreos Human Health B.V. Polypeptide mixes with antibacterial activity
EP3268023B1 (fr) 2015-03-12 2021-08-18 Micreos Human Health B.V. Combinaison d'un agent bactericide avec un agent alkalisant lysosomotropique pour le traitement d'une infection bacterienne
NO3144387T3 (fr) 2015-09-15 2018-08-11
US20200121744A1 (en) * 2016-11-08 2020-04-23 The Regents Of The University Of California Compositions and methods for treating skin diseases and maintaining healthy skin
EP3541406B1 (fr) 2016-11-18 2022-03-16 Lysando AG Nouveaux agents antimicrobiens contre staphylococcus aureus
BR112020019484A2 (pt) * 2018-03-29 2021-01-12 Contrafect Corporation Constructos polipeptídicos de lisina-peptídeo antimicrobiano (amp), lisinas, polinucleotídeos isolados codificando as mesmas e seus usos
US20210386835A1 (en) * 2018-11-19 2021-12-16 Conopco, Inc., D/B/A Unilever An antimicrobial composition for selectively inhibiting growth of p. acnes bacteria
TW202104254A (zh) * 2019-04-12 2021-02-01 美商格爾托公司 重組彈性蛋白及其生產
KR102097128B1 (ko) * 2019-06-19 2020-04-06 서울대학교산학협력단 황색포도상구균 제어에 효과적인 키메릭 엔도라이신 Lys109
CN115605587B (zh) * 2020-03-11 2026-02-13 特卢姆治疗有限公司 新型重组溶素及其在治疗革兰氏阴性菌感染中的用途
KR102358905B1 (ko) * 2020-05-20 2022-02-04 서울대학교산학협력단 황색포도상구균 유래 점보박테리오파지 PALS2 및 그 유래의 엔도라이신 LysPALS21과 LysPALS22
KR102314731B1 (ko) * 2020-07-02 2021-10-18 서울대학교산학협력단 황색포도상구균에 대한 높은 사멸 능력을 가진 재조합 엔도라이신 ClyC

Also Published As

Publication number Publication date
FR3149209A1 (fr) 2024-12-06

Similar Documents

Publication Publication Date Title
Souza et al. Plants from Brazilian Cerrado with potent tyrosinase inhibitory activity
Mueller et al. A review of topical therapy for skin infections with bacteria and yeast
Adler et al. Nitric oxide therapy for dermatologic disease
MA28328A1 (fr) Combinaisons d&#39;agents actifs synergiques fongicides
EP2111849A3 (fr) Utilisation d&#39;une composition cosmétique comprenant au moins un composé organique du silicium en association avec une composition de soin et/ou de lavage des fibres kératiniques
Ooi et al. Redox-active compounds with a history of human use: antistaphylococcal action and potential for repurposing as topical antibiofilm agents
WO2021123911A3 (fr) Composés d&#39;acides gras polymériques non ioniques pour le traitement de substrats fibreux à base d&#39;acides aminés, en particulier des cheveux
BR112022018500A2 (pt) Composição para cuidados pessoais, método para melhorar ou facilitar a deposição de composto ativo catiônico ou pseudocatiônico hidrófilo, e, uso da composição
FR2552305A1 (fr) Composition a pouvoir bactericide eleve contenant un biguanide et une pyrimidine
TW201536334A (zh) 包含精油組合物的抗微生物組成物
Mascarenhas-Melo et al. Dermatological bioactivities of resveratrol and nanotechnology strategies to boost its efficacy—An updated review
Abe et al. Antioxidant effects and antimicrobial activites of phytoncide
JOP20250026A1 (ar) تركيبة موضعية تجميلية لتحسين كثافة الشعيرات الدموية تحتوي على مستخلص زيتي على الأقل من بذور الـ &#34;مورينجا بيرجرينا&#34;، كمكون فعال، وطريقة لتحضير التركيبة وطريقة للعلاج التجميلي للشعر
FR3149207B1 (fr) Composition cosmétique comprenant une endolysine et un composé de formule (I)
FR3149202B1 (fr) Composition cosmétique comprenant une endolysine dérivée de phage de Staphylococcus aureus et une huile.
FR3149206B1 (fr) Composition cosmétique aqueuse comprenant une endolysine et du tréhalose
FR3149208B1 (fr) Composition cosmétique, notamment aqueuse, comprenant une endolysine et un pullulane
EP1870087A3 (fr) Utilisation de la coumarine, de butylated hydroxyanisole et d&#39;ethoxyquine pour le traitement de la canitie
FR3152394B1 (fr) Composition cosmétique comprenant une endolysine et des particules d’aérogel de silice hydrophobe
FR3149203B1 (fr) Composition anhydre comprenant une endolysine et de l’hydroxypropylmethylcellulose et/ou du pullulane
FR3149204B1 (fr) Composition cosmétique comprenant une endolysine et un tensioactif non ionique comprenant un résidu carbohydrate
BR112019027887A8 (pt) Mistura antimicrobiana, composição, processo de tratamento cosmético não terapêutico e processo para conservar uma composição
FR3149205B1 (fr) Composition cosmétique comprenant une endolysine et un agent de charge organique
FR3152393B1 (fr) Composition cosmétique comprenant une endolysine dérivée d’un phage de Staphylococcus aureus et une charge minérale
FR3149201B1 (fr) Composition cosmétique anhydre comprenant une endolysine dérivée de phage de Staphylococcus aureus et du mannitol.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20241206

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4